INS and diabetes mellitus: Novel treatments show promise in both liver and glycemic endpoints.<h4>Conclusion</h4>Phenotype-based diabetes subtypes exhibit distinct underlying pathophysiological mechanisms which shape the development of complications, with insulin resistance serving as the central link.